cMethDNA Multiplex PCR With STDgene Standards for Rare Methylated DNA
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing PCR-based methods for detecting tumor DNA in body fluids, such as serum or plasma, face challenges due to the low abundance of methylated DNA relative to unmethylated DNA, daily fluctuations in unmethylated DNA levels, inefficient primer hybridization, and the need for large DNA samples, leading to inaccurate and cumbersome clinical validation.
Innovation Solution
A novel quantitative multiplex methylation-specific PCR method (cMethDNA) using recombinantly engineered gene-specific standards (STDgene) as reference DNA, co-amplifying TARGETgene and STDgene with a single set of external primers, and calculating a cumulative methylation index (CMI) to enhance sensitivity and specificity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional PCR-based methods are used to detect tumor DNA in body fluids, then the detection can be performed with existing techniques, but the sensitivity is insufficient due to the low abundance of methylated DNA relative to unmethylated DNA
Solution Approach 1:
The detection method is divided into two sequential PCR steps: first an unmethylated DNA-specific PCR to remove abundant unmethylated DNA, then a methylated DNA-specific PCR to detect the rare methylated DNA. This segmentation allows each step to target specific DNA populations, dramatically improving detection sensitivity by eliminating the masking effect of abundant unmethylated DNA.
Solution Approach 2:
The first PCR step performs preliminary removal of unmethylated DNA templates before the second PCR step detects methylated DNA. By conducting this preliminary action of removing interfering unmethylated DNA, the method prepares the sample for highly sensitive methylated DNA detection in the second step.
2Device complexity
If a single set of external primers is used to co-amplify both TARGETgene and STDgene, then the assay complexity is reduced, but the primer hybridization efficiency becomes insufficient due to differences in primer binding to different gene sequences
Solution Approach 1:
The external primers are designed with local quality optimization: the 5' and 3' end sequences are identical between TARGETgene and STDgene to ensure equal hybridization efficiency, while the internal sequences differ to allow gene-specific amplification. This local quality approach allows a single primer set to reliably amplify both genes despite their overall sequence differences.
Solution Approach 2:
The primer design changes specific parameters: the primers are engineered to have identical binding sequences at the ends of both TARGETgene and STDgene amplicons, ensuring uniform hybridization kinetics and efficiency. This parameter change (identical end sequences) allows reliable co-amplification with a single primer set.
3Measurement precision
If nested PCR is used to pre-amplify target and reference DNA, then the sensitivity is improved, but the technical limitations arise due to differences in amplification efficiency between different gene regions
Solution Approach 1:
The STDgene is engineered to have homogeneous amplification characteristics with the TARGETgene by designing identical 5' and 3' end sequences that match the external primer binding sites. This homogeneity ensures that both genes are amplified with equal efficiency during the pre-amplification step, eliminating the efficiency differences that plague conventional nested PCR with disparate reference genes.
4Quantity of substance
If large amounts of serum are required for DNA extraction to obtain sufficient DNA for multiple gene assays, then the DNA quantity is sufficient, but the clinical validation becomes cumbersome and repeat studies become problematic
Solution Approach 1:
The method merges the detection of multiple genes (TARGETgene and STDgene) into a single multiplex PCR reaction using one pair of external primers. This merging allows sufficient DNA for multiple gene assays to be obtained from smaller serum volumes, as the DNA is efficiently utilized across multiple targets in parallel rather than requiring separate reactions for each gene.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
cMethDNA achieves >90% sensitivity and >96% specificity in detecting methylated DNA in serum, correlating with primary tumors and metastatic lesions, and monitoring treatment response with a small DNA input, overcoming previous methods' limitations.
Implementation Method 1
each single primer pair is capable of selectively hybridizing to only one of the TARGETgenes being detected and as well as the STDgene specific for that TARGETgene
Implementation Method 2
amplifying the DNA in (b) with one or more pairs of external methylation-independent PCR primers, where each single primer pair is capable of selectively hybridizing to only one of the TARGETgenes being detected and as well as the STDgene specific for that TARGETgene, using PCR under conditions sufficient to produce a first amplification product
Implementation Method 3
one or more optically detectable labeled DNA probes which specifically hybridize to a target sequence of each of TARGETgene, and one or more optically detectable labeled DNA probes which specifically hybridize to each STDgene
Data Source
AI summary
A cMethDNA method quantitatively detects tumor DNA (or other circulating DNAs) in fluids such as serum or plasma at the lowest copy number. Unique compared to any other PCR-based assay, a small number of copies of a synthetic polynucleotide standard (STDgene) is added to an aliquot of patient serum. A cocktail of standards for a plurality of genes of interest (TARGETgene) is added to a sample of serum. Once total DNA is purified and processed, a PCR (multiplex step) is performed wherein the STDgene and the TARGETgene are co-amplified with the same external primer set. In the second nested PCR step, amplicons present in a dilution of the first PCR reaction are subjected to real time PCR, and quantified for each gene in one well by two-color real-time PCR. Products are calculated by absolute quantitation with internal primer sets specific for the methylated TARGETgene and associated STDgene.